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Renal proximal tubular cells acquire resistance to cell death
stimuli in mice with hereditary tyrosinemia type 1.
Background. Hereditary tyrosinemia type 1 (HT1), which is
associated with severe liver and kidney damage, is caused by
deficiency of fumarylacetoacetate hydrolase (FAH), the last
enzyme of the tyrosine breakdown cascade. HT1-associated
liver and kidney failure can be prevented by blocking an
enzyme upstream of FAH in the tyrosine breakdown pathway
with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexane-
dione (NTBC). FAH knockout mice develop the HT1
phenotype when NTBC treatment is discontinued.
Methods. The occurrence of cell death was investigated in
kidneys of Fah−/− mice on and off NTBC either unchallenged
or injected with 800 mg/kg of homogentisic acid (HGA), an
intermediate of tyrosine breakdown.
Results. No cell death could be detected in kidneys of Fah−/−
mice on NTBC. A slight increase of cleaved caspase-3 was the
only apoptosis-related feature that could be detected in kid-
neys of Fah−/− mice off NTBC. Challenge of Fah−/− mice on
NTBC with HGA led to massive death of renal proximal tubu-
lar cells, with positive terminal deoxynucleotidyl transferase-
mediated deoxyuridine diphosphate (dUDP) nick-end labeling
(TUNEL) and DNA fragmentation assays, but hardly any cleav-
age of caspase-9 and caspase-3. Fah−/− mice off NTBC acquired
resistance to HGA-induced renal cell death and the kidneys ex-
hibited relatively few features of apoptosis upon challenge with
HGA, with a small increase in expression of cleaved caspase-9
and caspase-3.
Conclusion. Kidneys of adult Fah−/− mice, withdrawn from
NTBC for 15 days, reveal limited characteristics of apoptosis,
and have acquired resistance to a caspase-9- and caspase-3-
independent form of cell death provoked by HGA.
Hereditary tyrosinemia type 1 (HT1) is an autosomal-
recessive disorder caused by deficiency of fumarylace-
toacetate hydrolase (FAH) (EC 3.7.1.2), which catalyzes
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the final step of the tyrosine breakdown cascade [1].
FAH deficiency results in accumulation of its toxic sub-
strate fumarylacetoacetate (FAA) in liver and kidney
cells [2]. Inadequately treated HT1 patients with an early
onset of symptoms suffer from liver failure, which is
life-threatening and the main cause of death [3]. The
late presenting form, with an onset later than 6 months
after birth, has a less aggressive progression, and may
present with renal tubular dysfunction, known as the Toni
Fanconi syndrome [1, 3]. Tubular dilatation, involution of
epithelial cells, and some degree of glomerosclerosis were
noted in HT1 patients on low tyrosine diet of 18 months
to 17 years of age [4, 5].
The toxic actions of FAA are thought to be responsi-
ble for the hepatic damage and renal manifestations. Ac-
cumulation of FAA can be prevented by treating HT1
patients with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-
cyclohexanedione (NTBC/nitisinone) (Swedish Orphan
AB, Stockholm, Sweden), which blocks p-hydroxy-
phenylpyruvate dioxygenase (HPD), an enzyme acting
upstream of FAH [6] (Fig. 1). FAH knockout mice, gen-
erated by targeted disruption of the Fah gene [7], have a
neonatal lethal phenotype that can be rescued by admin-
istration of NTBC via the drinking water of the pregnant
and nursing female [8]. Withdrawal of NTBC treatment
from the drinking water of adult FAH-knockout mice
elicits the HT1 phenotype. NTBC only partially protects
FAH-deficient c14CoS/14CoS albino mice, which result from
a radiation-induced deletion comprising part of the Fah
gene and more than 80 additional genes [9–11].
It has been reported that FAA can induce cell death
both in vitro [12] and in vivo [13–15]. In double mutant
Hpd−/−/Fah−/− mice a single challenge with a high dose
of homogentisic acid (HGA) (Sigma Chemical Co., St.
Louis, MO, USA), a tyrosine metabolite and precursor of
FAA (Fig. 1), acutely evoked massive death of both hep-
atocytes and proximal tubular cells of the kidney [14, 15].
The authors suggested that the observed death of hepato-
cytes and tubular epithelial cells is due to accumulation of
FAA and that occurrence of FAA-induced cell death may
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Fig. 1. Tyrosine catabolic pathway. Fumarylacetoacetate hydrolase
(FAH) catalyses the last step of the tyrosine breakdown cascade. 2-(2-
nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) blocks
p-hydroxy-phenylpyruvate dioxygenase (HPD) upstream of FAH and
prevents accumulation of fumarylacetoacetate (FAA) due to FAH de-
ficiency. In the Hpd−/−/Fah−/− double mutant accumulation of FAA
is also absent. Administered homogentisic acid (HGA), which enters
the tyrosine breakdown pathway downstream of the block imposed by
NTBC, is converted to FAA independently of NTBC treatment.
contribute to the liver and kidney damage of untreated
HT1 patients. Extensive and rapid death of hepatocytes
could also be elicited by challenging NTBC-treated FAH
knockout mice with HGA [16]. Surprisingly, when FAH
knockout mice were taken off NTBC, their hepatocytes
acquired resistance to HGA-induced cell death and to
various other death-inducing stimuli. The observed re-
sistance appeared to be independent of the mode of cell
death. It is not clear yet how resistance to death-inducing
stimuli develops in hepatocytes of this mouse model. The
resistance of HT1-affected hepatocytes to cell death stim-
uli raises the questions whether FAA-induced cell death
does play a role in the progressive tissue damage of un-
treated HT1 patients and whether renal cells of FAH
knockout mice off NTBC are likewise prone to become
resistant to cell death stimuli. Knowledge of the behav-
ior of renal cells of the Fah−/− mice on and off NTBC
would both improve our insight into the pathophysio-
logic processes associated with the development of the
HT1 phenotype, and be a valuable tool in unraveling the
mechanisms that are involved in the acquisition of cell
death resistance.
The aim of the present study was to examine the oc-
currence and mode of cell death in kidneys of Fah−/−
mice, either on NTBC treatment or after withdrawal from
NTBC, and either unchallenged or after administration
of a highly toxic dose of HGA. We found that the inci-
dence of cell death in the unchallenged HT1-affected kid-
ney is small. Interestingly, renal proximal tubular cells of
Fah−/− mice off NTBC do develop insensitivity to the in-
duction of cell death, which could be evoked by HGA in
kidneys of Fah−/− mice receiving NTBC. The insensitiv-
ity to cell death could also be effectuated by pretreating
Fah−/− mice receiving NTBC with a low dose of HGA
before administration of a lethal dose of HGA. The re-
sistance to cell death stimuli of the kidney resulted in im-
proved survival of hepatocyte transplanted Fah−/− mice
off NTBC relative to hepatocyte transplanted Fah−/−
mice on NTBC after challenge with HGA.
METHODS
Animals and treatment
Four-month-old FAH knockout (FAHexon5, further
referred to as Fah−/−) mice (C57Bl/6) [8] and heterozy-
gous (Fah+/−) mice were maintained in a temperature-
controlled environment with a 12-hour light-dark cycle,
and allowed food ad libitum. Animals were treated ac-
cording to the guidelines of the Dutch Animal Ethical
Committee. All adult Fah−/− animals received drinking
water provided with NTBC/nitisinone at a dose of ap-
proximately 1 mg/kg body weight per day. NTBC was
provided from fetal stage on by treatment of the preg-
nant and nursing females (4 mg/kg body weight per day).
Experimental approach
To induce the HT1 phenotype adult Fah−/− mice were
withdrawn from NTBC treatment for 15 days. Adult
Fah−/− and Fah+/− mice on and off NTBC, which re-
ceived no further treatment, were sacrificed by cervi-
cal dislocation for assessment of kidney damage and the
presence of signs of cell death. Fah−/− and Fah+/− mice
on and off NTBC were injected intraperitoneally with
either a single dose of 800 mg/kg body weight of neu-
tralized HGA or were sham-injected with phosphate-
buffered saline (PBS). The mice were sacrificed 1, 2, and
4 hours after injection. In a second experiment Fah−/−
mice on and off NTBC were injected intraperitoneally
with a low dose of 100 mg/kg body weight of HGA. One
group of mice was sacrificed 1 hour after injection and a
second group received an additional dose of 800 mg/kg
HGA intraperitoneally 1 hour after the first injection.
The mice of this group were sacrificed 4 hours after chal-
lenge with 800 mg/kg HGA. The control and experimen-
tal groups consisted of two to four age-matched mice. Of
each mouse one kidney was snap-frozen in liquid nitro-
gen and stored at −70◦C until analysis, and one kidney
was fixed in 4% phosphate-buffered paraformaldehyde
(PFA) or in a mixture containing a 2:2:1 ratio of
methanol:acetone:water (MAW).
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Biochemical analysis of succinylacetone
Urine samples were taken just before sacrifice of the
mice and frozen at −70◦C. After decapitation blood
was collected by dabbing the wound onto Parafilm M
(Pechiney Plastic Packaging, Inc., Neenah, WI, USA)
and immediately mixed with sodium-heparin. Plasma was
separated from the red blood cells by brief centrifugation
and frozen at −70◦C. Urine and plasma concentration of
succinylacetone was quantified using a stable isotope di-
lution gas chromatography-mass spectrometry (GS-MS)
assay as described earlier [17].
Histologic examinations
For microscopic examination PFA-fixed kidneys were
dehydrated in a series of graded ethanol and embed-
ded in paraffin wax at 58◦C. Sections of 1.5 lm were
used for silver staining with periodic acid methenamine
silver (PAMS) followed by staining with hematoxylin
and eosin. Histologic evaluation of the slides was per-
formed by an independent external expert in kidney-
pathology. For immunohistochemistry and histologic
detection of apoptotic nuclei MAW-fixed kidneys were
dehydrated in series of graded ethanol and embedded in
paraffin wax at 58◦C. Eight-micron sections were used
for analysis. Immunohistochemical detection of the pro-
cessed form of caspase-3 was performed using an an-
tibody against cleaved caspase-3 (1:50 dilution) (Cell
Signaling Technology, Beverly, MA, USA) according to
the manufacturer’s instructions. The primary antibody
and the peroxidase-conjugated goat-antirabbit IgG sec-
ondary antibody (1:200) (Dako Corporation, Carpinte-
ria, CA, USA) were incubated overnight at 4◦C and for
30 minutes at room temperature, respectively. Pro-
tein was visualized using 3,3′-diaminobenzidine (DAB).
Hematoxylin was used as counterstain.
The 3′-OH DNA ends generated by DNA fragmen-
tation were determined using the terminal deoxynu-
cleotidyl transferase-mediated deoxyuridine diphos-
phate (dUDP) nick-end labeling (TUNEL) assay
(Promega, Madison, WI, USA), according to the man-
ufacturer’s manual. The detection system uses an
antidioxigenin antibody conjugated with peroxidase
and visualization with DAB. Light green was used as
counterstain.
Analysis of DNA fragmentation
For detection of DNA fragmentation snap-frozen kid-
ney tissues were minced using a glass Teflon homogenizer.
Total DNA was isolated using the Puregene DNA iso-
lation kit (Gentra Systems, Inc., Minneapolis, MN, USA)
and 5 lg of the DNA preparations was applied to a 1.8%
agarose gel containing ethidium-bromide. DNA ladder-
ing was visualized under ultraviolet illumination.
Immunoblot analysis
Frozen tissues were homogenized in ice-cold
25 mmol/L potassium inorganic phosphate (KPi) buffer
(pH 7.4) containing 2.5 lg/mL leupeptin, 10 lg/mL
antipain, 0.2 mmol/L phenylmethylsulfonyl fluoride
(PMSF), and 0.2 mmol/L ethylenediaminetetraacetic
acid (EDTA) using a glass Teflon homogenizer, followed
by centrifugation at 14,000g for 10 minutes at 4◦C. Pro-
tein concentration of the supernatant was determined
with the Bio-Rad protein assay (Hercules, CA, USA).
Protein samples were subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred onto Hybond-P membranes (Amer-
sham Pharmacia Biotech, Buckinghamshire, UK) by
electrophoric transfer (Bio-Rad) using 20% ethanol,
0.15 mol/L glycin, 0.025% SDS, 0.02 mol/L Tris HCl,
pH 7, as transfer buffer. The nonspecific antibody-
binding activities of the membranes were blocked in
Tris-buffered saline containing 0.1% (vol/vol) Tween
20 and 5% (wt/vol) nonfat dry milk (Protifar, Nutricia,
Zoetermeer, The Netherlands) for 1 hour at room
temperature. Incubations with appropriate dilutions of
primary antibodies against cleaved caspase-3 (1:1000)
and caspase-9 (1:1000) (Cell Signaling Technology,
Beverly, MA, USA) were carried out overnight at 4◦C in
blocking buffer. Bound primary antibody was detected
with horseradish peroxidase-conjugated secondary
antibodies (1:10,000) and chemiluminescence (ECL +
plus) (Amersham Pharmacia Biotech), according to
the manufacturer’s instructions. Ponceau S staining was
used to visualize protein loading, as the expression of
housekeeping genes, which is strongly influenced by the
HT1 phenotype, cannot be used as loading control.
Liver cell transplantation
Parenchymal hepatocytes were isolated from congenic
wild-type animals by a two-step collagenase perfusion
method [16]. Cell number and viability were deter-
mined by Trypan blue exclusion in a hemocytometer.
The donor cells were resuspended in DMEM (Gibco-
BRL, Gaithersburg, MD, USA) with 15% fetal calf serum
(FCS) and 250,000 viable cells were injected intraspleni-
cally [18, 19] into Fah−/− recipient mice. All mutant
animals were kept on NTBC until the time of transplanta-
tion. Immediately after transplantation mice were with-
drawn from NTBC. The weights of experimental mice
were measured weekly. All mice had at least regained
their preoperational weight within 5 weeks following the
transplantation procedure. After 3 months one group
of hepatocyte-transplanted Fah−/− mice was returned to
NTBC-treatment for 2 weeks. Transplanted Fah−/− mice
on and off NTBC were injected intraperitoneally with
100, 200, 300, 500, or 800 mg/kg body weight of neutral-
ized HGA. Every experimental group consisted of two to
five age-matched animals. Mice of which the livers could
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be harvested immediately after death showed similar re-
population with Fah+/+ hepatocytes (50–90%) as surviv-
ing mice sacrificed after 20 days of survival.
RESULTS
Animal models
The FAH knockout mouse model was used to inves-
tigate the deleterious effects of continuous exposure to
FAA and of highly toxic single HGA stimuli on the kid-
ney. Fah−/− mice receiving NTBC had a high serum ty-
rosine level (600 to 800 lmol/L) caused by the NTBC
treatment, but revealed no other clinical or biochemical
signs of disease. Kidneys of these animals were macro-
scopically normal. For examination of the effect of a
continuous FAA stimulus Fah−/− mice were withdrawn
from NTBC for 15 days. This time point was chosen be-
cause the mice still have the same weight and overall
health as controls, but they do have liver and kidney dys-
function. It has previously been shown that HT1 mice
have marked hyperbilirubinemia, elevation of transami-
nases, and histologic abnormalities of the liver at this time
point [8, 20]. All Fah−/− mice already developed gluco-
suria and proteinuria 6 days after NTBC withdrawal (data
not shown). Plasma and urine levels of succinylacetone
were markedly elevated after withdrawal of NTBC for
15 days and varied from 0.10 to 0.40 lmol/L in plasma
(N = 5, normal value <0.01 lmol/L) and from 1.72 to
12.48 lmol/L in urine (N = 5, normally undetectable).
The kidneys of Fah−/− mice off NTBC were enlarged
and had a pale color. For the study of the effect of a sin-
gle toxic HGA stimulus both NTBC-treated Fah−/− mice
and Fah−/− mice that had been off NTBC for 15 days
were injected intraperitoneally with a dose of 800 mg/kg
body weight HGA. HGA-challenged animals on NTBC
treatment showed major signs of discomfort, such as de-
crease in body temperature and lack of explorative fea-
tures, starting approximately 2 to 3 hours after injection
with 800 mg/kg of HGA. Upon harvesting, their kidneys
were found to have normal size and color. Challenge with
800 mg/kg of HGA had clearly less observable effects on
mice that suffered from HT1 after NTBC withdrawal.
This was indicative of a diminished sensitivity to acute
HGA toxicity. The kidneys of these mice were enlarged
and pale, similar as was found for the Fah−/− mice that
had been off NTBC for 15 days but not challenged with
800 mg/kg of HGA. All Fah+/− mice on and off NTBC
did not experience any discomfort after HGA injection.
Their kidneys were normal, independent of NTBC and
HGA administration. To explore whether the apparent
resistance to toxicity of a single dose of 800 mg/kg of
HGA could also be elicited by preadministration of a
low dose of HGA, Fah−/− mice on and off NTBC were
injected with 100 mg/kg of HGA and subsequently ei-
ther sacrificed after 1 hour, or injected with an additional
dose of 800 mg/kg of HGA and sacrificed after another
4 hours. All Fah−/− mice that sequentially received
100 mg/kg of HGA and 800 mg/kg of HGA showed few
signs of discomfort and were relatively resistant to the
toxicity of HGA in comparison with Fah−/− mice on
NTBC that were injected only with 800 mg/kg of HGA.
The results described above are summarized in Table 1.
Histologic analysis of kidneys of Fah−/− mice
on and off NTBC and of Fah−/− mice on and
off NTBC injected with HGA
NTBC-treated Fah−/− mice showed normal morpho-
logic appearances of all renal structures with no signs of
kidney damage (Fig. 2A). Massive kidney damage with
manifestations of apoptosis, such as loss of cell-cell adhe-
sion and nuclear shrinkage as well as chromatin degra-
dation, was detected in epithelial cells of the proximal
tubules of NTBC-treated Fah−/− mice 4 hours after chal-
lenge with a toxic dose of 800 mg/kg HGA (Fig. 2C). The
appearance of wide lumina of a relative large amount of
tubules indicated cytoplasmic shrinkage. No vacuoliza-
tion of the cytoplasm was observed. Debris of protein was
detected in the lumina of various proximal tubules. The
appearance of glomeruli, interstitial cells, and blood ves-
sels was normal. A small number of distal tubular cells
showed damage. The distribution of the observed kid-
ney damage overlapped the expression pattern of FAH
in wild-type kidneys [11].
A continuous exposure of Fah−/− mice to FAA accu-
mulation, imposed by withdrawal of NTBC for 15 days,
resulted in tubular dilatation of the kidney and enlarge-
ment of tubules, but no histologic signs of apoptotic cell
death could be detected (Fig. 2B). Fah−/− mice with-
drawn from NTBC, in which ameliorated behavioral
characteristics suggested diminished sensitivity to HGA
toxicity, showed substantial changes in renal morphology
upon challenge with 800 mg/kg HGA, including apop-
totic features of a few proximal tubular cells (Fig. 2D).
However, in contrast to what is seen in NTBC-treated
Fah−/− mice injected with 800 mg/kg of HGA, the his-
tologic features of apoptosis were limited to only a few
proximal epithelial cells.
Intraperitoneal injection of 100 mg/kg HGA did not
change the morphology in kidneys of either NTBC-
treated Fah−/− mice or Fah−/− mice off NTBC (Fig. 2E
and F), compared to kidneys of appropriate control
mice (Fig. 2A and B). Tubular epithelial cells of Fah−/−
mice on NTBC, which first received 100 mg/kg HGA,
were severely damaged 4 hours after administration of
800 mg/kg HGA, but the histologic hallmarks of apop-
tosis were absent (Fig. 2G). Fah−/− mice off NTBC that
received 100 mg/kg HGA similarly showed no features
of apoptosis after subsequent injection with 800 mg/kg of
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HGA (Fig. 2H). The kidneys of Fah+/− mice on and off
NTBC did not show any abnormalities with or without
HGA challenge (data not shown).
Analysis of cell death by TUNEL and DNA
fragmentation assays in kidneys of Fah−/− mice
on and off NTBC and of Fah−/− mice on and off
NTBC injected with HGA
To further analyze the mode of cell death TUNEL and
DNA fragmentation assays were performed. Both assays
were negative in kidneys of unchallenged NTBC-treated
Fah−/− mice (Figs. 3A and 4). The TUNEL assay yielded
extensive positively stained nuclei in kidney sections of
Fah−/− mice on NTBC, examined 2 (not shown) and
4 hours after injection with 800 mg/kg of HGA (Fig. 3C).
TUNEL-positive nuclei were predominantly located in
the proximal tubules. No positive nuclei were found in
glomeruli and distal tubules. DNA fragmentation was de-
tected after 2 hours in the kidneys of these mice (Fig. 4),
and was equally apparent 4 hours after HGA injection.
The continuous FAA stimulus, evoked by a 15 days
withdrawal from NTBC, did not yield detectable
TUNEL-positive nuclei in the kidney of Fah−/− mice
(Fig. 3B), suggesting that the incidence of cell death is
small at this stage of the disease. This result is corrobo-
rated by the absence of DNA fragmentation (time point
0, Fig. 4). To investigate if HT1-affected kidneys remain
sensitive to induction of acute cell death by a single toxic
HGA stimulus, Fah−/− mice withdrawn from NTBC were
challenged with 800 mg/kg HGA. Markedly fewer mani-
festations of cell death were seen in kidneys of these mice
in comparison with kidneys of similarly treated Fah−/−
mice on NTBC. Four hours after HGA injection only a
small number of nuclei were TUNEL-positive (Fig. 3D),
and DNA fragmentation was barely detectable in kidneys
of Fah−/− mice off NTBC (Fig. 4).
Prevention of cell death upon injection of 800 mg/kg
HGA was likewise achieved by preadministration of
100 mg/kg of HGA to Fah−/− mice on NTBC. Injec-
tion of 100 mg/kg HGA alone did not yield TUNEL-
positive nuclei in kidneys of NTBC-treated Fah−/− mice,
although some DNA fragmentation was noticed (Figs. 3E
and 4). Subsequent injection of 800 mg/kg HGA did not
result in the appearance of TUNEL-positive nuclei within
4 hours after injection or in increase of DNA fragmen-
tation (Figs. 3F and 4). The findings described above are
summarized in Table 1.
Cleavage of caspase-9 and caspase-3 in kidneys of Fah−/−
mice on and off NTBC and of Fah−/− mice on and off
NTBC injected with HGA
It has been suggested that caspases play a role in HGA-
induced cell death in the kidneys of FAH-deficient mice
[15]. To determine the involvement of caspases in cell
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Fig. 2. Histologic analysis of the effect of homogentisic acid (HGA)
on kidneys of Fah−/− mice on and off 2-(2-nitro-4-trifluoro-
methylbenzoyl)-1,3-cyclohexanedione (NTBC). Kidneys of Fah−/−
mice on (A, C, E, and G) and off (B, D, F, and H) NTBC, which were
exposed to various forms of treatment (see also Table 1), were analyzed
for the presence of damage by hematoxylin and eosin and silver staining
(PAMS), as described in the Methods section. Kidney sections (1.5 lm)
are shown of mice that were intraperitoneally injected with phosphate-
buffered saline (PBS) (A and B), 800 mg/kg HGA (C and D), 100 mg/kg
HGA (E and F), and 100 mg/kg HGA 1 hour prior to challenge with
800 mg/kg HGA (G and H). Mice were sacrificed 4 hours after injection
with PBS or 800 mg/kg HGA (A, B, C, D, G, and H). Mice that only
received 100 mg/kg HGA were sacrificed after 1 hour (E and F). Arrow-
heads indicate nuclear shrinkage with chromatin degradation in renal
epithelial tubular cells; arrows indicate loss of cell-cell adhesion; aster-
isks indicate intraluminal debris of protein (C) (original magnification
×400).
death of renal proximal tubular cells we investigated the
presence of processed caspase-9 and caspase-3 in kid-
neys of our mouse model, before and after challenge
with HGA. The antibody against caspase-9 detects both
uncleaved (inactive) and cleaved (activated) caspase-
9, whereas the antibody against cleaved caspase-3 only
detects the activated form of caspase-3. Immunoblot
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Fig. 3. Influence of homogentisic acid (HGA) challenge on the ap-
pearance of terminal deoxynucleotidyl transferase-mediated dUDP
nick-end labeling (TUNEL)-positive nuclei in kidneys of Fah−/− mice
on and off 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione
(NTBC). Kidneys of Fah−/− mice on (A, C, E, and F) and off (B and D)
NTBC, which received different treatments (see also Table 1), were an-
alyzed for the presence of apoptotic nuclei, using the TUNEL assay (see
the Methods section). The 3′-OH DNA ends generated by DNA frag-
mentation were visualized with 3,3′-diaminobenzidine (DAB). Light
green was used as counter stain. Kidney sections (8 lm) are shown of
mice, intraperitoneally injected with phosphate-buffered saline (PBS)
(A and B), 800 mg/kg HGA (C and D), 100 mg/kg HGA (E), and 100
mg/kg HGA 1 hour prior to challenge with 800 mg/kg HGA (F). Mice
were sacrificed 4 hours after injection with PBS or 800 mg/kg HGA
(A, B, C, D, and F). Mice, which only received 100 mg/kg HGA were
sacrificed after 1 hour (E). Positive nuclei (indicated by arrowheads)
are visible in most of the epithelial cells of the proximal tubules 4 hours
after HGA administration in NTBC-treated mice (C). A slight num-
ber of nuclei from proximal tubular epithelial cells were stained after
injection with HGA in kidney sections of mice withdrawn from NTBC
(D). Preadministration of 100 mg/kg HGA prevented the appearance
of TUNEL-positive nuclei (F). Distal tubuli and glomeruli did not re-
veal positive nuclei in kidneys of any of the mouse models (original
magnification ×100, insets ×400 magnification).
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Fig. 4. Influence of homogentisic acid (HGA) challenge on time-
dependent DNA fragmentation in kidneys of Fah−/− mice on and off 2-
(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC). (A)
Fah−/− mice on and off NTBC were intraperitoneally injected with 800
mg/kg HGA and sacrificed 1 hour, 2 hours, or 4 hours after challenge
with 800 mg/kg HGA. As a control, unchallenged Fah−/− mice on and
off NTBC were used (−). (B) Fah−/− mice on and off NTBC were
intraperitoneally injected with 100 mg/kg HGA and sacrificed 1 hour
later, or injected with 100 mg/kg HGA 1 hour prior to challenge with
800 mg/kg HGA, and sacrificed 4 hours after the second injection. DNA
was isolated from snap-frozen kidneys (see Methods section) and 5 lg
of the DNA preparations was applied to a 1.8% agarose gel containing
ethidium bromide. DNA was visualized under ultraviolet illumination.
analysis showed no indication of cleavage of caspase-9
in kidneys of Fah−/− mice on and off NTBC (Fig. 5A).
Minimal cleavage of caspase-9 was seen in kidneys of
Fah−/− mice on NTBC 2 and 4 hours after injection with
800 mg/kg of HGA (Fig. 5A, left panel), while the
TUNEL and DNA laddering assays were strongly posi-
tive in kidneys of these mice (Figs. 3C and 4). Apparently,
there is no association of the processing of caspase-9 and
the massive HGA-induced cell death in the kidneys of
Fah−/−mice on NTBC. Preadministration of 100 mg/kg
of HGA to Fah−/− mice on NTBC prevented cleavage
of caspase-9 after administration of 800 mg/kg of HGA
(Fig. 5A, middle panel). A slight cleavage of caspase-
9 was detected in kidneys of Fah−/− mice off NTBC
1, 2, and 4 hours after administration of 800 mg/kg of
HGA (Fig. 5A, left panel). This cleavage of caspase-9
was not detectable when Fah−/− mice off NTBC were in-
jected with 100 mg/kg of HGA prior to administration of
800 mg/kg of HGA (Fig. 5A, middle panel).
Immunoblot analysis, using the antibody against
cleaved caspase-3, revealed a higher expression of
cleaved caspase-3 in kidneys of mice off NTBC, before
and after administration of 800 mg/kg of HGA, relative
to the cleaved caspase-3 expression in kidneys of the re-
spective mice on NTBC (Fig. 5B left panel). The amount
of cleaved caspase-3 was slightly elevated by challenge
with 800 mg/kg of HGA of both Fah−/−mice on NTBC
and Fah−/−mice off NTBC (Fig. 5B, left panel). This im-
plies that no association exists between cleaved caspase-3
expression and the extensive renal cell death, which only
occurs in kidneys of Fah−/− mice on NTBC injected with
800 mg/kg of HGA. No increase in expression of cleaved
caspase-3 was observed in kidneys of Fah−/− mice on
and off NTBC injected with 100 mg/kg of HGA prior
to administration of 800 mg/kg of HGA (Fig. 5B, mid-
dle panel). The cleaved caspase-3 protein could not be
detected in kidneys of any of the mice tested using im-
munohistochemistry (Fig. 5C and D, and data not shown).
Caspase-3 cleavage could readily be found in the intesti-
nal control tissue (Fig. 5E). These findings indicate that
the massive cell death in kidneys of Fah−/− mice on
NTBC challenged with 800 mg/kg of HGA takes place
via caspase-9- and caspase-3-independent mechanisms.
Influence of HGA challenge on survival of
hepatocyte-transplanted Fah−/− mice on and off NTBC
Recently it has been reported that Fah−/− mice, which
had been withdrawn from NTBC for 2 weeks, survive
an otherwise lethal dose of HGA [16]. We investigated
whether the acquired resistance to HGA-induced cell
death in kidneys of Fah−/− mice off NTBC in itself suf-
fices to cause prolonged survival of these mice. To exclude
the effect of liver pathology on mortality, Fah−/− mice
were transplanted with wild-type liver cells. All trans-
planted mice recovered completely from tyrosinemia ini-
tially elicited by NTBC withdrawal and stayed healthy
without NTBC for at least 3 months after transplantation.
One group of Fah+/+ hepatocyte-transplanted Fah−/−
mice was returned to NTBC treatment for 2 weeks, the
other group was not treated with NTBC. Transplanted
mice were injected intraperitoneally with varying doses
of HGA. After injection with 800 mg/kg HGA mice both
on and off NTBC died within 3 days (data not shown),
indicating that the dose of 800 mg/kg HGA is still lethal
despite observed resistance to cell death measured 4
hours after injection. However, injection with 500, 300,
or 200 mg/kg HGA, doses which are also capable to in-
duce extensive cell death in the kidney of Hpd−/−/Fah−/−
double-mutant mice [15], resulted in prolonged survival
of hepatocyte-transplanted Fah−/− mice off NTBC com-
pared to hepatocyte transplanted Fah−/− mice on NTBC
upon injection with the same dose of HGA (Fig. 6).
All mice that received 100 mg/kg HGA showed long-
term survival, independent of NTBC treatment (data not
shown).
DISCUSSION
In Hpd−/−/Fah−/− double mutant mice retrieval of the
tyrosine catabolic pathway by either HGA challenge or
administration of recombinant adenovirus expressing hu-
man HPD cDNA, evokes an acute induction of massive
cell death in liver and kidney [14, 15]. As NTBC blocks
the activity of HPD, Fah−/− mice treated with NTBC are
comparable to the Hpd−/−/Fah−/− double mutant mice.
This is underscored by the observation that extensive
death of hepatocytes could also be elicited by challenging
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Fig. 5. Analysis of processing of caspase-9 and -3 after homogentisic acid (HGA)-induced injury in kidneys of Fah−/− mice on and off 2-(2-nitro-
4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC). Homogenates of snap-frozen kidneys were used for immunoblot analysis. Either 20 mg
(A) or 80 mg (B) of protein was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to nitrocellulose,
and probed with an antibody against caspase-9 (A), which detects both the uncleaved (inactive) and cleaved (activated) form, or an antibody against
cleaved caspase-3 (B), as described in the Methods section. Fah−/− mice on and off NTBC were intraperitoneally injected with 800 mg/kg HGA
and sacrificed 1 hour, 2 hours, or 4 hours after challenge with 800 mg/kg HGA (left panels). As a control, unchallenged Fah−/− mice on and off
NTBC were used (−). Fah−/− mice on and off NTBC were intraperitoneally injected with 100 mg/kg HGA and sacrificed 1 hour later, or injected
with 100 mg/kg HGA 1 hour prior to challenge with 800 mg/kg HGA, and sacrificed 4 hours after the second injection (middle panels). Protein (20
mg) extracted from mouse ileum was used as a positive control for both antibodies (right panels). ∗The exposure time used for detection of cleaved
caspase-3 in ileum was 10 minutes, whereas an overnight exposure was necessary for detection of cleaved caspase-3 in kidney. Ponceau S staining
confirmed comparable protein loading for the different samples (data not shown). Expression of cleaved caspase-3 was analyzed in 8 lm kidney
sections of Fah−/− mice on (C) and off (D) NTBC 4 hours after challenge with 800 mg/kg HGA. Sections were probed with an antibody against
cleaved caspase-3 and visualized using a peroxidase-conjugated secondary antibody and 3,3′-diaminobenzidine (DAB) as a substrate (see Methods
section). An 8 lm ileum section was used as a positive control for the cleaved caspase-3 antibody (E) (original magnification ×400).
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Fig. 6. Influence of homogentisic acid
(HGA) challenge on survival of hepatocyte-
transplanted Fah−/− mice on and off 2-(2-
nitro-4-trifluoromethylbenzoyl)-1,3-cyclo-
hexanedione (NTBC). Fah−/− mice were
transplanted intrasplenically with 250,000
wild-type hepatocytes and subsequently
taken off NTBC. After metabolic correction
of the hereditary tyrosinemia type 1 (HT1)
phenotype one group of animals was returned
to NTBC treatment for 2 weeks (closed sym-
bols), another group did not receive NTBC
(open symbols). Transplanted mice were
injected intraperitoneally with 500 (A), 300
(B), or 200 (C) mg/kg HGA. Survival was
examined after HGA challenge. Hepatocyte
transplanted Fah−/− mice that were not
treated with NTBC showed prolonged
survival when compared to mice on NTBC
receiving equal doses of HGA. ∼Represents
mice that showed long-term survival.
NTBC-treated FAH knockout mice with 500 mg/kg of
HGA [16] and by our finding that a stimulus with 800
mg/kg of HGA gives a massive death of renal proxi-
mal tubular cells in Fah−/− mice on NTBC (Figs. 3 and
4). The hepatocytes and the renal proximal tubular cells
of the HGA-challenged Hpd−/−/Fah−/− double mutant
mice revealed the histologic hallmarks of apoptosis and
TUNEL-positive nuclei [14, 15]. The liver of the Fah−/−
mice on NTBC injected with 500 mg/kg of HGA [16] and
the kidneys of Fah−/− mice on NTBC receiving 800 mg/kg
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of HGA [this report] similarly showed histologic features
of apoptosis, extensive TUNEL-positive cells, and posi-
tive DNA laddering assays. Both TUNEL and ladder-
ing assays, however, do not always discriminate between
apoptosis and necrosis [21–23].
Analysis of the expression of caspases in kidneys of our
mouse models (Fig. 5) shows that the renal cell death of
the HGA-challenged Fah−/− mice on NTBC is not associ-
ated with marked cleavage of caspase-9, nor with substan-
tial cleavage of caspase-3, indicating that this form of cell
death is largely caspase-9- and caspase-3-independent. In
livers of NTBC-treated Fah−/− mice significant cleavage
of the precursor form of caspase-9 was evident 3 hours af-
ter induction with 500 mg/kg of HGA [16]. But the cleav-
age of caspase-9 was not accompanied by high activities
of caspase-9 nor of caspase-3, implying that hepatocyte
death in this mouse model is at least in part caspase-
independent [16]. The limited cleavage of caspase-9
detected in our experiments may be a kidney-specific
phenomenon or be attributed to the higher dose of HGA
that we used to induce cell death. Previous reports of
HGA- and FAA-induced cell death suggested involve-
ment of caspases to a large degree [12–15]. FAA-induced
apoptosis of Chinese hamster cells in vitro was associ-
ated with cytochrome c release and caspase-3 activity,
which peaked 24 to 32 hours and 32 hours after FAA ex-
posure, respectively [12]. Apoptotic cell death in this in
vitro model could be prevented by pretreatment with an
inhibitor of caspase-3 activity. In kidneys of Fah−/− mice
on NTBC laddering and TUNEL assays are already pos-
itive 2 hours after administration of 800 mg/kg of HGA
(Figs. 3 and 4). The livers of Fah−/− mice on NTBC re-
vealed positive DNA laddering assays 6 hours after in-
jection of 500 mg/kg of HGA [16]. The relatively large
time lag between cell death stimulus and effect, found in
Chinese hamster cells, suggests that the model of these in
vitro studies concerns a milder insult, possibly due to the
fact that the cells are not deficient for FAH. Apparently, a
relationship exists between the mechanism of cell death
and the strength of the damaging insult. In kidneys of
Hpd−/−/Fah−/− double mutant mice HGA-induced cell
death could be prevented in vivo by preadministration of
acetyl-Tyr-Val-Ala-Asp-CHO (YVAD) [15], an inhibitor
of caspase-1. The activation of caspase-1, however, does
not necessarily coincide with activation of caspase-9 and
-3 [24]. Caspase-1 activity has also been implicated in
necrosis of renal proximal tubular cells [25]. Our finding
that cleavage of caspase-9 and caspase-3 is not involved
in renal cell death of Fah−/− mice on NTBC challenged
with 800 mg/kg of HGA suggests that the cells die by an-
other mechanism than the classic caspase-mediated form
of apoptosis.
To further investigate the involvement of cell death
in the progression of HT1-induced kidney damage we
examined kidneys of Fah−/− mice of which the NTBC
treatment was discontinued for 15 days. Retrieval of the
tyrosine breakdown cascade by withdrawal of NTBC
leads to a gradual accumulation of FAA in liver and kid-
ney as the tissue levels of NTBC slowly decrease [26].
NTBC withdrawal will, therefore, more closely resem-
ble the pathophysiologic situation in which progressive
kidney damage accompanying the HT1 phenotype de-
velops than the challenge provided by a single high dose
of HGA. Interestingly, the level of cleaved caspase-3 is
increased in kidneys of Fah−/− mice off NTBC relative
to the cleaved caspase-3 levels in kidneys of Fah−/− mice
on NTBC, suggesting that some activation of apoptotic
pathways occurs. The expression of cleaved caspase-3 in
kidneys of Fah−/− mice off NTBC was neither associated
with histologic manifestations of cell death (Fig. 2), nor
with positive TUNEL and DNA laddering assays (Figs. 3
and 4), indicating that the absolute amount of activated
caspase-3 was low. This is underscored by the weak signal
of cleaved caspase-3 in renal tissue of our mouse models,
relative to the cleaved caspase-3 signal in intestinal tissue
(Fig. 5B, right panel).
Interestingly, the renal proximal tubular cells of Fah−/−
mice off NTBC developed strong resistance to HGA-
induced cell death, similarly as has been reported for
HT1-affected hepatocytes. The acquired resistance of re-
nal proximal tubular cells is independent of the existence
of HT1-associated liver disease, as the administration of
various doses of HGA leads to prolonged survival of
Fah−/− mice off NTBC with a liver partially repopulated
by Fah+/+ cells relative to Fah−/− mice on NTBC trans-
planted with Fah+/+ hepatocytes (Fig. 6).
Acquired resistance of kidney cells to cell death stim-
uli has been described in other models. Miyaji et al [27]
and Sano et al [28] found an acquired resistance of the
kidney to rechallenge injury by cisplatin and uranyl ac-
etate, respectively. In these models the single stimulus of
a kidney-damaging agent elicits two peaks of apoptosis
in the kidneys of mice and rats in vivo. The first peak
represents apoptosis of proximal tubular cells due to the
direct action of the damaging agent, whereas the second
peak reflects the removal of excess regenerating cells in
the recovery phase. When a second insult is imposed dur-
ing the recovery phase, the kidney appears to be rela-
tively resistant to the induction of additional apoptosis.
The resistance to cell death found in kidneys of Fah−/−
mice withdrawn from NTBC may not be the result of a
recovery phase, since NTBC withdrawal leads to a slow
accumulation of FAA, and extensive cell death occurs
when high doses of HGA are administered with a sin-
gle intraperitoneal injection [15]. This suggests that there
are various mechanisms that lead to effectuation of re-
sistance to cell death in the kidney. Our finding that ad-
ministration of 100 mg/kg HGA, a dose that Fah−/− mice
survive with only minor changes of biochemical parame-
ters, also prevents massive cell death when injected just
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1 hour prior to a toxic dose of HGA, is an example of
yet another mechanism. However, it is still possible that
a common denominator lies at the basis of the refractory-
like behavior of the cells that have become insensitive to
cell death stimuli. Retrieval of the tyrosine breakdown
cascade in Fah−/− mice is associated with oxidative stress
[9, 11, 20, 29, 30]. Induction of oxidative stress in liver
of Fah−/− mice on NTBC by administration of ethanol
sufficed to cause resistance of hepatocytes to cell death
stimuli [16]. The altered physicochemical properties of
the cell accompanying oxidative stress may change the
processing of incoming signals and, thus, induce the ob-
served insensitivity to external death-inducing stimuli.
It is important to define the key players in the im-
plementation of resistance to various cell death stimuli
in HT1-affected tissues. As we have shown previously,
the HT1 phenotype, elicited by withdrawing Fah−/− mice
from NTBC for 15 days, leads to massive changes in liver
gene expression [20]. Transcripts encoding cell death–
stimulating proteins and cell death–inhibiting proteins
were shown to be induced simultaneously. This implies
that establishment of changes in actions of individual pro-
teins will not suffice to suggest a mechanistic role in the
effectuation of cell death resistance. Changes in gene ex-
pression can also be found in kidneys of Fah−/− mice off
NTBC, but these changes clearly differ from that of the
liver (data not shown). The finding that renal cells of these
mice are likewise prone to become resistant to cell death
stimuli provides a tool to search for factors which show
an equivalent reaction in HT1-affected liver and kidney
after administration of HGA and, thus, are more likely
to be involved in the implementation of resistance to cell
death.
CONCLUSION
We report that rapid and massive caspase-9 and
caspase-3 independent cell death occurs in kidneys of
Fah−/− mice on NTBC, however, only under circum-
stances of acute excessive FAA accumulation. Continu-
ous accumulation of FAA induced by NTBC withdrawal
from Fah−/− mice elicits resistance to renal cell death and
promotes survival of hepatocyte-transplanted Fah−/−
mice off NTBC challenged with HGA. Administration
of 100 mg/kg of HGA to NTBC-treated Fah−/− mice
1 hour prior to a high toxic dose of HGA mimics the
effect of continuous accumulation of FAA with respect
to the acquired resistance to cell death in the kidney. It
will be very important to investigate the various mech-
anisms that lead to the effectuation of resistance to this
form of cell death, as the inability to eliminate harmed
cells is a potential danger to the organism. It is already
known that patients with HT1 are at risk for developing
hepatocellular carcinoma, even under NTBC treatment
[31]. It cannot be excluded that the susceptibility of the
HT1-affected kidney to develop resistance to cell death
stimuli will have harmful effects when HT1 patients be-
come older, now that NTBC treatment and liver trans-
plantation have greatly improved their life expectancies
[6, 31, 32]. Further exploration of acquired resistance to
cell death will be facilitated by the experimental mouse
model described in this report.
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